Evidence map›Paper›PMID 37934312›Full record

ArticleJournal of cancer survivorship : research and practice2024

Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study.

Mylène Duivon, Marie Lange, Giulia Binarelli, Johan Lefel, Isabelle Hardy-Léger, Régine Kiasuwa-Mbengi, Jean-Baptiste Méric, Cécile Charles, Florence Joly

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07755839 (CanCOG® - Cognitive Rehabilitation in Cancer), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07755839 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

CanCOG® - Cognitive Rehabilitation in Cancer: A Protocol for a Multicenter Pilot Randomized Controlled Trial With Non-central Nervous System Cancer Survivors

TypeinterventionalSponsorAveiro UniversityRan2026 to 2028Enrolled60ConditionsCancer-related Cognitive Impairment, Cancer-related Cognitive Dysfunction, Cancer-related Cognitive Difficulties, Depression and Anxiety SymptomsArmsCanCOG® - Cogntive Rehabilitation in Cancer
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Methodology of analysis of cognitive impairment in longitudinal randomized clinical trials in oncology: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  8. Cancer-related cognitive impairment in adult cancer survivors: a clinical practice review for healthcare providers.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Mylène DuivonNormandie Univ, UNICAEN, INSERM, ANTICIPE, 14000, Caen, France.
Marie LangeNormandie Univ, UNICAEN, INSERM, ANTICIPE, 14000, Caen, France.
Giulia BinarelliNormandie Univ, UNICAEN, INSERM, ANTICIPE, 14000, Caen, France.
Johan LefelCare Support Department, Centre Henri Becquerel, 76000, Rouen, France.
Isabelle Hardy-LégerHopital Cochin, 75014, Paris, France.
Régine Kiasuwa-MbengiDepartment of Public Health and Epidemiology, Belgian Cancer Centre, Sciensano, Brussels, Belgium.
Jean-Baptiste MéricPublic Health Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
Cécile CharlesBordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.
Florence JolyNormandie Univ, UNICAEN, INSERM, ANTICIPE, 14000, Caen, France. f.joly@baclesse.unicancer.fr.
Université de Caen Normandie · FRCentre François Baclesse · LUCentre Henri BecquerelHôpital Cochin · FRInstitut National du Cancer · FRSciensano (Belgium) · BEUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCancer-related cognitive impairment (CRCI) is under-addressed by healthcare professionals owing to a lack of clinical management guidelines. This European Delphi study proposes recommendations to healthcare professionals for the management of CRCI in patients with non-central nervous system (non-CNS) cancers.

methodsTwenty-two recommendations were developed based on a literature review and authors' clinical experience, split into three categories: screening, cognitive assessment, intervention. The survey included European professionals, experts in CRCI. The Delphi method was used: experts rated the clinical relevancy of recommendations on a 9-point Likert scale in three rounds. A recommendation was accepted if all votes were between 7 and 9. Recommendations not accepted in round 1 and round 2 were deleted, or modified and rated in round 3.

resultsEighteen professionals (psychologists, physicians, researchers) voted and accepted 15 recommendations. Experts recommended the systematic screening of CRCI, followed by a short objective cognitive assessment, if complaints screened. A comprehensive evaluation is recommended if CRCI persists 6 months post-treatment. Cognitive rehabilitation, physical activity, meditative-movement therapy, and multimodal intervention should be offered. Recommendations about frequency and duration of interventions, the professional to administer cognitive rehabilitation and the use of meditation and cognitive training without psychoeducation were not accepted.

conclusionsThis survey provides 15 recommendations to assist healthcare professionals in detecting, assessing and offering interventions for CRCI. IMPLICATIONS FOR CANCER SURVIVORS: These recommendations should be included in supportive care to help healthcare professionals to detect CRCI and propose the best available intervention for patients with cognitive complaints. Developing CRCI management in clinical settings would improve patients' quality of life.

Indexed as

Cognitive DysfunctionDelphi TechniqueNeoplasmsDisease ManagementEuropeFemaleHumansMaleCancerCancer-related cognitive impairmentCognitive rehabilitationDelphi methodNon-pharmacological interventionsScreening

Identifiers

PMID37934312
PMCPMC11502546
OpenAlexW4388457132

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.